Communiqués Universe Pharmaceuticals INC

Actions

UPC

KYG9442G1385

Produits pharmaceutiques

Marché Fermé - Nasdaq 22:30:00 06/10/2026			Varia. 5j.	Varia. 1 janv.
4,210 ^USD	-3,00%		-6,86%	+10,50%

29/09	Universe Pharmaceuticals dépose une déclaration d’enregistrement préalable mixte de 200 millions de dollars	MT
02/09	Les plus fortes hausses en pré-séance	MT

Communiqués

30/06	Sizzling Stocks Under $5: UPC, ANY, NNBR, DCOY Target AI Infrastructure, Data Centers, Pharmaceutical Innovation and Biotechnology Growth	AQ
26/06	Universe Pharmaceuticals INC Announces Strategic Acquisition to Expand Pharmaceutical Patent Portfolio	AQ
11/02	Universe Pharmaceuticals INC Announces Effective Date of Dual-Class Share Structure	AQ
20/03/25	Universe Pharmaceuticals INC Announces Share Consolidation	AQ
25/02/25	Universe Pharmaceuticals INC Receives Staff Determination Notice from Nasdaq Related to Delayed Annual Report	AQ
03/02/25	Universe Pharmaceuticals INC Receives Nasdaq Delisting Notice Subject to Hearing Request	AQ
12/12/24	Universe Pharmaceuticals : Announces $15 Million Registered Direct Offering Form 6 K	PU
10/12/24	Univest Securities, LLC Announces Closing of $15 Million Registered Direct Offering for its Client Universe Pharmaceuticals INC (NASDAQ: UPC)	AQ
09/12/24	Universe Pharmaceuticals INC Announces $15 Million Registered Direct Offering	AQ
13/11/24	UNIE PHARPAR : Universe Pharmaceuticals INC Announces Share Consolidation Form 6 K	PU
13/11/24	Universe Pharmaceuticals INC Announces Share Consolidation	GL
01/11/24	Universe Pharmaceuticals : Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency Form 6 K	PU
01/11/24	Universe Pharmaceuticals INC Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency	GL
10/10/24	Universe Pharmaceuticals INC. CIK Number: 0001809616 Form 6 K	PU
27/09/24	Universe Pharmaceuticals : Results of the Universe Pharmaceuticals INC 2024 Annual General Meeting Form 6 K	PU
20/09/24	Universe Pharmaceuticals INC Reports Financial Results for The First Six Months of Fiscal Year 2024	AQ
18/07/24	Universe Pharmaceuticals : Closing of Public Offering Form 6 K	PU
30/01/24	Universe Pharmaceuticals INC Reports Fiscal Year 2023 Financial Results	PR
16/08/23	Universe Pharmaceuticals : Receipt of Nasdaq Notification Regarding Compliance with Nasdaq Minimum Bid Price Requirement - Form 6-K	PU
04/08/23	Universe Pharmaceuticals INC Announces Receipt of Nasdaq Notification Regarding Minimum Market Value of Publicly Held Shares	AQ
27/07/23	Universe Pharmaceuticals INC Announces Share Consolidation	AQ
05/07/23	Universe Pharmaceuticals : Results of the Universe Pharmaceuticals INC 2023 Annual General Meeting - Form 6-K	PU
07/03/23	Universe Pharmaceuticals INC Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency	AQ
21/12/22	Universe Pharmaceuticals INC Announces Inclusion of Six Products into the First Edition of Catalogue of Medicine for Patients Infected with COVID-19	AQ
14/11/22	Universe Pharmaceuticals INC Regains Compliance with Nasdaq Minimum Bid Price Requirement	AQ